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Abstract
A new method of determination of genetically predetermined type of biotransformation by acetylation rate using
reversed-phase liquid chromatography (RP-HPLC) was described. The method is based on determination of
isonicotinic hydrazide (INH) which is excreted with the patient’s urine during 24 h period after oral administration
of 0.4 g of the drug. INH is used as pharmacogenetic marker. Precolumn derivatization of 4-chloro-5,7-dinitrobenzo-
furazan is used at RP-HPLC determination of INH and a new drug phosphabenzide (diphenylphosphinylacetic
hydrazide, DPPAH) with specrtophotometric detection in urine. The limit of INH detection was 0.27 mg ml1 and
the one of DPPAH was 0.82 mg ml1. As a result of pharmacokinetic investigation it was discovered that bimodal
distribution by acetylation rate for DPPAH is less apparent than in the case of INH. It is shown, that immunomod-
ulator xymedone (N-(b-oxyethyl)-4,6-dimethyldihydropirimidon-2) is the acetylation inductor of xenobiotics. © 1998
Elsevier Science B.V. All rights reserved.
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1. Introduction
Clarification of the connection between concen-
tration of xenobiotics, their metabolites and phar-
macological effect is the base of effective and
secure application of drugs as well as diagnostics
and treatment of personnel exposed to industrial
toxicants [1–4]. In connection with this, the task
of the development of sensitive and selective
methods of determination of drugs and other
xenobiotics in biological substrates of a human
being is very urgent. The availability of relatively
simple and clinically applicable methods for the
determination of drugs in biological substrates for
diagnostics of genetically predetermined type of
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